AKEEGA™ (niraparib and abiraterone acetate) JOHNSON & JOHNSON HK Reg. No. HK-68296 (09 Jul, 2024) & HK-68295 (09 Jul, 2024) Composition: 2 AKEEGA™ is a combination of niraparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, an...
The Uro-Oncology Asia 2021 Significant advances in urological cancer treatments have been emerging in recent years. For instance, immunotherapy continues to play an increasingly important role and innovations in biomarkers help select patients for s...
Erectile dysfunction can reduce sexual intimacy and negatively influence the psychological well-being in both the affected men and their partners. Besides, erectile dysfunction can be an early sign of cardiovascular disease, especially in younger me...